Scholarlink

Abstract <p>Develop an improved lymph node evaluation system for prognosis prediction in esophageal squamous cell carcinoma (ESCC) patients receiving neoadjuvant therapy.</p> Methods <p>Studied 282 ESCC patients who underwent neoadjuvant chemoradiotherapy (NCRT) and surgery. Evaluated lymph node factors like number, size, location, and intra-nodal cancer status. Developed and validated a prognostic model using these factors.</p> Results <p>Cases with a clearance of 17–30 lymph nodes during surgery showed improved overall survival (OS) compared to those with fewer than 17 or more than 30 cleared nodes. Patients with a lower tumor regression grade of lymph nodes (LN-TRG) experienced improved OS and recurrence-free survival (RFS). Patients with LN extracapsular invasion had worse OS and RFS. Abdominal lymph nodes showed the highest ratio of residual cancer, highest hazard ratio (HR), and the largest number and proportion of positive cases. The five most relevant factors for prognosis, as revealed by Lasso regression and Cox univariate analysis, were LN-TRG, LN total tumor diameter, the clearance of 17–30 lymph nodes, the proportion of positive lymph nodes, and LN extracapsular invasion. The predictive model, based on these factors, achieved good risk stratification for OS and RFS (AUC = 0.705, 0.679), surpassing pathology N (pN) staging.</p> Conclusion <p>A comprehensive lymph node assessment using a predictive model enables improved prognosis prediction and risk stratification compared to pN staging for patients undergoing neoadjuvant therapy. This approach contributes to the accurate evaluation of clinical prognosis and assists in guiding treatment strategies.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Enhanced prognosis prediction model in esophageal cancer via lymph node assessment post-neoadjuvant

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年9月30日

查看全文
  • Yehan Zhou,
  • Meng Xiao,
  • Jiayu Li,
  • Hong Yang,
  • Yi Wang,
  • Qifeng Wang,
  • Xuefeng Leng,
  • Wenwu He,
  • Yongyao Han,
  • Zongyao Huang,
  • Yang Liu

摘要

Abstract

Develop an improved lymph node evaluation system for prognosis prediction in esophageal squamous cell carcinoma (ESCC) patients receiving neoadjuvant therapy.

Methods

Studied 282 ESCC patients who underwent neoadjuvant chemoradiotherapy (NCRT) and surgery. Evaluated lymph node factors like number, size, location, and intra-nodal cancer status. Developed and validated a prognostic model using these factors.

Results

Cases with a clearance of 17–30 lymph nodes during surgery showed improved overall survival (OS) compared to those with fewer than 17 or more than 30 cleared nodes. Patients with a lower tumor regression grade of lymph nodes (LN-TRG) experienced improved OS and recurrence-free survival (RFS). Patients with LN extracapsular invasion had worse OS and RFS. Abdominal lymph nodes showed the highest ratio of residual cancer, highest hazard ratio (HR), and the largest number and proportion of positive cases. The five most relevant factors for prognosis, as revealed by Lasso regression and Cox univariate analysis, were LN-TRG, LN total tumor diameter, the clearance of 17–30 lymph nodes, the proportion of positive lymph nodes, and LN extracapsular invasion. The predictive model, based on these factors, achieved good risk stratification for OS and RFS (AUC = 0.705, 0.679), surpassing pathology N (pN) staging.

Conclusion

A comprehensive lymph node assessment using a predictive model enables improved prognosis prediction and risk stratification compared to pN staging for patients undergoing neoadjuvant therapy. This approach contributes to the accurate evaluation of clinical prognosis and assists in guiding treatment strategies.